Loomis, Sayles & Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11M | Buy |
43,544
+16,941
| +64% | +$3.64M | 0.01% | 373 |
|
|
2026
Q1 | $5.79M | Sell |
26,603
-1,535
| -5% | -$341K | 0.01% | 402 |
|
|
2025
Q4 | $6.43M | Sell |
28,138
-10,769
| -28% | -$2.45M | 0.01% | 404 |
|
|
2025
Q3 | $9.01M | Sell |
38,907
-15,088
| -28% | -$3.07M | 0.01% | 372 |
|
|
2025
Q2 | $10M | Buy |
53,995
+18,866
| +54% | +$3.51M | 0.01% | 380 |
|
|
2025
Q1 | $7.36M | Sell |
35,129
-44,285
| -56% | -$8.61M | 0.01% | 392 |
|
|
2024
Q4 | $14.1M | Buy |
79,414
+824
| +1% | +$151K | 0.02% | 316 |
|
|
2024
Q3 | $15.5M | Sell |
78,590
-136,317
| -63% | -$25.4M | 0.02% | 299 |
|
|
2024
Q2 | $36.9M | Buy |
214,907
+44,821
| +26% | +$7.42M | 0.05% | 163 |
|
|
2024
Q1 | $31M | Sell |
170,086
-106,412
| -38% | -$18.3M | 0.04% | 195 |
|
|
2023
Q4 | $42.8M | Buy |
276,498
+19,285
| +7% | +$2.81M | 0.07% | 141 |
|
|
2023
Q3 | $38.3M | Buy |
257,213
+211,591
| +464% | +$31.1M | 0.07% | 146 |
|
|
2023
Q2 | $6.15M | Sell |
45,622
-8,521
| -16% | -$1.25M | 0.01% | 381 |
|
|
2023
Q1 | $8.63M | Sell |
54,143
-1,075
| -2% | -$164K | 0.02% | 346 |
|
|
2022
Q4 | $8.92M | Sell |
55,218
-1,692
| -3% | -$259K | 0.02% | 328 |
|
|
2022
Q3 | $7.64M | Sell |
56,910
-134,496
| -70% | -$19.3M | 0.02% | 334 |
|
|
2022
Q2 | $29.3M | Sell |
191,406
-110,700
| -37% | -$16.9M | 0.05% | 173 |
|
|
2022
Q1 | $49M | Sell |
302,106
-39,231
| -11% | -$5.7M | 0.07% | 131 |
|
|
2021
Q4 | $46.2M | Buy |
341,337
+340,755
| +58,549% | +$40.3M | 0.06% | 163 |
|
|
2021
Q3 | $63K | Hold |
582
| – | – | ﹤0.01% | 583 |
|
|
2021
Q2 | $66K | Buy |
582
+123
| +27% | +$13.9K | ﹤0.01% | 580 |
|
|
2021
Q1 | $50K | Buy |
459
+89
| +24% | +$9.52K | ﹤0.01% | 565 |
|
|
2020
Q4 | $40K | Sell |
370
-10,932
| -97% | -$1.05M | ﹤0.01% | 556 |
|
|
2020
Q3 | $989K | Sell |
11,302
-257
| -2% | -$24.2K | ﹤0.01% | 454 |
|
|
2020
Q2 | $1.14M | Sell |
11,559
-2,446
| -17% | -$215K | ﹤0.01% | 438 |
|
|
2020
Q1 | $1.07M | Sell |
14,005
-13,371
| -49% | -$1.14M | ﹤0.01% | 445 |
|
|
2019
Q4 | $2.42M | Sell |
27,376
-29,328
| -52% | -$2.43M | ﹤0.01% | 430 |
|
|
2019
Q3 | $4.29M | Sell |
56,704
-2,242
| -4% | -$154K | 0.01% | 410 |
|
|
2019
Q2 | $4.29M | Sell |
58,946
-5,699
| -9% | -$448K | 0.01% | 433 |
|
|
2019
Q1 | $5.21M | Buy |
64,645
+10,096
| +19% | +$826K | 0.01% | 422 |
|
|
2018
Q4 | $5.03M | Buy |
54,549
+50,378
| +1,208% | +$4.43M | 0.01% | 417 |
|
|
2018
Q3 | $394K | Sell |
4,171
-3,234
| -44% | -$307K | ﹤0.01% | 573 |
|
|
2018
Q2 | $686K | Buy |
7,405
+1
| +0% | +$98 | ﹤0.01% | 562 |
|
|
2018
Q1 | $701K | Sell |
7,404
-3,684
| -33% | -$405K | ﹤0.01% | 577 |
|
|
2017
Q4 | $1.07M | Sell |
11,088
-5,122
| -32% | -$483K | ﹤0.01% | 563 |
|
|
2017
Q3 | $1.44M | Sell |
16,210
-6,473
| -29% | -$493K | ﹤0.01% | 554 |
|
|
2017
Q2 | $1.65M | Sell |
22,683
-153
| -0.7% | -$10.3K | ﹤0.01% | 549 |
|
|
2017
Q1 | $1.49M | Buy |
22,836
+2,488
| +12% | +$156K | ﹤0.01% | 558 |
|
|
2016
Q4 | $1.27M | Sell |
20,348
-564,063
| -97% | -$34.4M | ﹤0.01% | 583 |
|
|
2016
Q3 | $36.9M | Sell |
584,411
-186,107
| -24% | -$12M | 0.09% | 128 |
|
|
2016
Q2 | $47.7M | Sell |
770,518
-124,779
| -14% | -$7.6M | 0.13% | 99 |
|
|
2016
Q1 | $51.1M | Buy |
895,297
+14,376
| +2% | +$801K | 0.15% | 103 |
|
|
2015
Q4 | $52.2M | Buy |
880,921
+165,647
| +23% | +$9.54M | 0.15% | 98 |
|
|
2015
Q3 | $38.9M | Buy |
715,274
+707,967
| +9,689% | +$46.1M | 0.12% | 138 |
|
|
2015
Q2 | $491K | Sell |
7,307
-2,538
| -26% | -$166K | ﹤0.01% | 612 |
|
|
2015
Q1 | $576K | Sell |
9,845
-1,865
| -16% | -$113K | ﹤0.01% | 636 |
|
|
2014
Q4 | $766K | Sell |
11,710
-30,962
| -73% | -$1.95M | ﹤0.01% | 582 |
|
|
2014
Q3 | $2.46M | Sell |
42,672
-445
| -1% | -$24.7K | 0.01% | 562 |
|
|
2014
Q2 | $2.43M | Sell |
43,117
-797
| -2% | -$41.8K | 0.01% | 578 |
|
|
2014
Q1 | $2.26M | Buy |
43,914
+1,137
| +3% | +$57.5K | 0.01% | 567 |
|
|
2013
Q4 | $2.26M | Sell |
42,777
-367,234
| -90% | -$18M | 0.01% | 597 |
|
|
2013
Q3 | $18.3M | Sell |
410,011
-70,985
| -15% | -$3.15M | 0.06% | 358 |
|
|
2013
Q2 | $19.9K | Buy |
+480,996
| New | +$21M | 0.07% | 302 |
|
Other funds holding ABBV
Loomis, Sayles & Company's ABBV Position: Q2 2026 in Review
Loomis, Sayles & Company increased its AbbVie (ABBV) stake by 64% in Q2 2026, buying an estimated $3.64M and bringing the position to 43,544 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #373.
Loomis, Sayles & Company first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $52.2M in Q4 2015. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Loomis, Sayles & Company held 43,544 shares of AbbVie worth $11M as of Q2 2026.
- Loomis, Sayles & Company bought 16,941 AbbVie shares in Q2 2026, an estimated $3.64M.
- AbbVie made up 0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #373 holding.
- Loomis, Sayles & Company first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Loomis, Sayles & Company's AbbVie position peaked at $52.2M in Q4 2015.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.